Publicaciones internacionales
Aquí le ofrecemos una selección de publicaciones científicas relacionadas con la inmunoterapia IOZK.
Puede utilizar los filtros para hacer una selección según tipos de tumores y métodos, o introducir términos de búsqueda.
HN Protein of Newcastle Disease Virus Induces Apoptosis Through SAPK/JNK Pathway
Recombinant Newcastle Disease Virus Encoding IL-12 and/or IL-2 as Potential Candidate for Hepatoma Carcinoma Therapy
Prospective study of cyclophosphamide, thiotepa, carboplatin combined with adoptive DC-CIK followed by metronomic cyclophosphamide therapy as salvage treatment for triple negative metastatic breast cancers patients (aged <45)
Therapeutic hyperthermia: The old, the new, and the upcoming
Dendritic cell-based immunotherapy targeting Wilms‘ tumor 1 in patients with recurrent malignant glioma
Enhancement of the Immunostimulatory Functions of Ex Vivo-Generated Dendritic Cells from Early-Stage Colon Cancer Patients by Consecutive Exposure to Low Doses of Sequential-Kinetic-Activated IL-4 and IL-12. A Preliminary Study
The therapeutic effect of death: Newcastle disease virus and its antitumor potential
Route of antigen delivery impacts the immunostimulatory activity of dendritic cell-based vaccines for hepatocellular carcinoma
Suplemento ZEIT: Vivir con cáncer con un artículo sobre el IOZK y la inmunoterapia IOZK
Viral Infection of Tumors Overcomes Resistance to PD-1-immunotherapy by Broadening Neoantigenome-directed T-cell Responses
Vaccination of multiple myeloma: Current strategies and future prospects
Phase I study of combination of antitumor immunotherapy targeted against cytomegalovirus (CMV) plus regulatory T-cell inhibition in patients with newly diagnosed glioblastoma multiforme (GBM).
Brain Tumor Immunotherapy: What have We Learned so Far?
Caso práctico del IOZK sobre la supervivencia a largo plazo de una paciente con cáncer de mama
Re-irradiation or re-operation followed by dendritic cell vaccination? Comparison of two different salvage strategies for relapsed high-grade gliomas by means of a new prognostic model
Artículo del Prof. Dr. Schirrmacher en el semanario médico vienés "Skriptum".
Definitive radiotherapy with concurrent oncothermia for stage IIIB non-small-cell lung cancer: A case report
Recombinant Immunomodulating Lentogenic or Mesogenic Oncolytic Newcastle Disease Virus for Treatment of Pancreatic Adenocarcinoma
Rationale for a Multimodality Strategy to Enhance the Efficacy of Dendritic Cell-Based Cancer Immunotherapy
Comparative impact of treatment on clinical benefit in patients with glioblastoma (GBM) enrolled in the phase II trial of ICT-107.